Financial Ratios PT Industri Jamu dan Farmasi Sido Muncul Tbk
Equities
SIDO
ID1000130305
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
500.00 IDR | 0.00% |
|
-2.91% | -15.25% |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 19.51 | 24.96 | 21.21 | 19.32 | 23.69 | |||||
Return on Total Capital | 22.88 | 29.46 | 24.74 | 22.32 | 26.93 | |||||
Return On Equity % | 29.72 | 37.68 | 31.67 | 27.59 | 34.07 | |||||
Return on Common Equity | 29.72 | 37.68 | 31.67 | 27.59 | 34.07 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 55.13 | 56.85 | 55.95 | 56.61 | 58.71 | |||||
SG&A Margin | 20.78 | 18.06 | 20.38 | 21.73 | 21.1 | |||||
EBITDA Margin % | 37.65 | 41.88 | 38.56 | 37.77 | 40.61 | |||||
EBITA Margin % | 34.54 | 39.32 | 35.78 | 34.56 | 37.86 | |||||
EBIT Margin % | 34.54 | 39.32 | 35.78 | 34.56 | 37.86 | |||||
Income From Continuing Operations Margin % | 28 | 31.36 | 28.58 | 26.66 | 29.88 | |||||
Net Income Margin % | 28 | 31.36 | 28.58 | 26.66 | 29.88 | |||||
Net Avail. For Common Margin % | 28 | 31.36 | 28.58 | 26.66 | 29.88 | |||||
Normalized Net Income Margin | 22.47 | 25.07 | 22.95 | 21.35 | 24.08 | |||||
Levered Free Cash Flow Margin | 21.22 | 20.03 | 17.75 | 22.04 | 21.16 | |||||
Unlevered Free Cash Flow Margin | 21.23 | 20.05 | 17.76 | 22.05 | 21.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.9 | 1.02 | 0.95 | 0.89 | 1 | |||||
Fixed Assets Turnover | 2.11 | 2.53 | 2.4 | 2.24 | 2.55 | |||||
Receivables Turnover (Average Receivables) | 5.59 | 6.06 | 5.72 | 4.83 | 4.72 | |||||
Inventory Turnover (Average Inventory) | 4.92 | 4.53 | 3.41 | 3.25 | 3.85 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.66 | 4.13 | 4.06 | 4.47 | 5.36 | |||||
Quick Ratio | 3.03 | 3.22 | 2.98 | 3.51 | 4.2 | |||||
Operating Cash Flow to Current Liabilities | 1.85 | 2.21 | 2.05 | 2.28 | 2.8 | |||||
Days Sales Outstanding (Average Receivables) | 65.46 | 60.27 | 63.77 | 75.51 | 77.53 | |||||
Days Outstanding Inventory (Average Inventory) | 74.43 | 80.55 | 107.05 | 112.18 | 95.06 | |||||
Average Days Payable Outstanding | 42.56 | 38.05 | 40.59 | 51.21 | 40.6 | |||||
Cash Conversion Cycle (Average Days) | 97.33 | 102.76 | 130.23 | 136.48 | 131.99 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.22 | 0.25 | 0.07 | 0.28 | 0.09 | |||||
Total Debt / Total Capital | 0.22 | 0.25 | 0.07 | 0.28 | 0.09 | |||||
LT Debt/Equity | 0.13 | 0.07 | - | 0.1 | - | |||||
Long-Term Debt / Total Capital | 0.13 | 0.07 | - | 0.1 | - | |||||
Total Liabilities / Total Assets | 16.31 | 14.69 | 14.11 | 12.97 | 11.47 | |||||
EBIT / Interest Expense | 2.78K | 2.14K | 2.15K | 2.27K | 1.14K | |||||
EBITDA / Interest Expense | 3.03K | 2.28K | 2.32K | 2.49K | 1.22K | |||||
(EBITDA - Capex) / Interest Expense | 2.8K | 2.11K | 2.04K | 2.39K | 1.18K | |||||
Total Debt / EBITDA | 0.01 | 0.01 | 0 | 0.01 | 0 | |||||
Net Debt / EBITDA | -0.82 | -0.64 | -0.62 | -0.61 | -0.54 | |||||
Total Debt / (EBITDA - Capex) | 0.01 | 0.01 | 0 | 0.01 | 0 | |||||
Net Debt / (EBITDA - Capex) | -0.88 | -0.69 | -0.7 | -0.63 | -0.55 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.74 | 20.55 | -3.87 | -7.75 | 9.9 | |||||
Gross Profit, 1 Yr. Growth % | 9.41 | 24.32 | -5.4 | -6.92 | 13.98 | |||||
EBITDA, 1 Yr. Growth % | 11.81 | 34.09 | -11.47 | -9.64 | 18.97 | |||||
EBITA, 1 Yr. Growth % | 11.73 | 37.26 | -12.52 | -10.91 | 20.4 | |||||
EBIT, 1 Yr. Growth % | 11.73 | 37.26 | -12.52 | -10.91 | 20.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 15.64 | 35 | -12.39 | -13.95 | 23.18 | |||||
Net Income, 1 Yr. Growth % | 15.64 | 35 | -12.39 | -13.95 | 23.18 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.15 | 34.5 | -12.01 | -14.16 | 23.94 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 15.64 | 35.77 | -12.9 | -13.95 | 23.18 | |||||
Accounts Receivable, 1 Yr. Growth % | 25.38 | 0.05 | 3.4 | 14.86 | 10.51 | |||||
Inventory, 1 Yr. Growth % | 3.42 | 47.43 | 18.93 | -24.73 | 5.78 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.61 | 1.49 | 1.03 | -3.06 | -3.47 | |||||
Total Assets, 1 Yr. Growth % | 9.07 | 5.7 | 0.31 | -4.67 | 1.26 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.51 | 8.13 | 1.05 | -3.5 | 3.1 | |||||
Common Equity, 1 Yr. Growth % | 5.12 | 7.74 | 0.99 | -3.41 | 3.01 | |||||
Cash From Operations, 1 Yr. Growth % | 23.76 | 15.79 | -7.69 | -4.67 | 9.05 | |||||
Capital Expenditures, 1 Yr. Growth % | -30.73 | 28.81 | 45.57 | -71.76 | -9.22 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 34.58 | 13.8 | -14.84 | 14.56 | 6.79 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 34.62 | 13.82 | -14.84 | 14.54 | 6.85 | |||||
Dividend Per Share, 1 Yr. Growth % | 28.16 | 21.57 | -3.65 | -16.16 | 27.45 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.87 | 14.49 | 7.65 | -5.83 | 0.69 | |||||
Gross Profit, 2 Yr. CAGR % | 13.62 | 16.63 | 8.45 | -6.03 | 3 | |||||
EBITDA, 2 Yr. CAGR % | 19.57 | 22.44 | 8.95 | -10.56 | 3.32 | |||||
EBITA, 2 Yr. CAGR % | 18.8 | 23.84 | 9.58 | -11.72 | 3.57 | |||||
EBIT, 2 Yr. CAGR % | 18.8 | 23.84 | 9.58 | -11.72 | 3.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.62 | 24.94 | 8.75 | -13.17 | 2.96 | |||||
Net Income, 2 Yr. CAGR % | 18.62 | 24.94 | 8.75 | -13.17 | 2.96 | |||||
Normalized Net Income, 2 Yr. CAGR % | 17.58 | 22.27 | 8.78 | -13.1 | 3.14 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 18.61 | 25.3 | 8.75 | -13.42 | 2.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | 27.26 | 12 | 1.71 | 8.98 | 12.67 | |||||
Inventory, 2 Yr. CAGR % | -0.28 | 23.48 | 32.41 | -5.38 | -10.77 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.73 | 0.44 | 1.26 | -1.04 | -3.26 | |||||
Total Assets, 2 Yr. CAGR % | 7.4 | 7.37 | 2.97 | -2.22 | -1.75 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.75 | 6.81 | 4.53 | -1.25 | -0.26 | |||||
Common Equity, 2 Yr. CAGR % | 5.35 | 6.43 | 4.31 | -1.24 | -0.25 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.62 | 19.71 | 3.39 | -6.19 | 1.96 | |||||
Capital Expenditures, 2 Yr. CAGR % | -37.93 | -5.54 | 36.94 | -35.88 | -49.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.29 | 23.75 | -1.56 | -1.23 | 9.94 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 22.31 | 23.79 | -1.55 | -1.23 | 9.97 | |||||
Dividend Per Share, 2 Yr. CAGR % | 32.08 | 24.82 | 8.23 | -10.13 | 3.37 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.02 | 13.32 | 8.01 | 2.25 | -0.85 | |||||
Gross Profit, 3 Yr. CAGR % | 15.78 | 17.08 | 8.77 | 3.16 | 0.22 | |||||
EBITDA, 3 Yr. CAGR % | 21.42 | 24.23 | 9.9 | 2.36 | -1.86 | |||||
EBITA, 3 Yr. CAGR % | 21.58 | 24.66 | 10.29 | 2.27 | -2.1 | |||||
EBIT, 3 Yr. CAGR % | 21.58 | 24.66 | 10.29 | 2.27 | -2.1 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.5 | 23.84 | 11 | 0.59 | -2.43 | |||||
Net Income, 3 Yr. CAGR % | 20.5 | 23.84 | 11 | 0.59 | -2.43 | |||||
Normalized Net Income, 3 Yr. CAGR % | 20.76 | 22.97 | 9.57 | 0.52 | -2.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.5 | 24.08 | 11 | 0.59 | -2.62 | |||||
Accounts Receivable, 3 Yr. CAGR % | 15.81 | 17.45 | 9.06 | 5.92 | 9.49 | |||||
Inventory, 3 Yr. CAGR % | 4.92 | 13.6 | 21.94 | 9.69 | -1.8 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.06 | 0.98 | 0.63 | -0.2 | -1.85 | |||||
Total Assets, 3 Yr. CAGR % | 6.82 | 6.83 | 4.96 | 0.36 | -1.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.41 | 6.54 | 4.86 | 1.78 | 0.18 | |||||
Common Equity, 3 Yr. CAGR % | 3.62 | 6.14 | 4.58 | 1.67 | 0.16 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.36 | 12.32 | 9.78 | 0.63 | -1.36 | |||||
Capital Expenditures, 3 Yr. CAGR % | -34.92 | -20.83 | 9.11 | -19.09 | -28 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 59.93 | 19.39 | 9.26 | 3.55 | 0.97 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 59.41 | 19.41 | 9.28 | 3.55 | 0.98 | |||||
Dividend Per Share, 3 Yr. CAGR % | 29.38 | 28.48 | 14.5 | -0.6 | 0.97 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.5 | 9.44 | 8.47 | 5.23 | 5.02 | |||||
Gross Profit, 5 Yr. CAGR % | 15.92 | 16.45 | 12.79 | 7.22 | 6.49 | |||||
EBITDA, 5 Yr. CAGR % | 18.06 | 21.51 | 16.27 | 8.93 | 7.22 | |||||
EBITA, 5 Yr. CAGR % | 19.21 | 22.11 | 16.63 | 8.59 | 7.55 | |||||
EBIT, 5 Yr. CAGR % | 19.21 | 22.11 | 16.63 | 8.59 | 7.55 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.38 | 21.28 | 15.66 | 7.45 | 7.71 | |||||
Net Income, 5 Yr. CAGR % | 16.38 | 21.28 | 15.66 | 7.45 | 7.71 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.44 | 20.72 | 15.82 | 7.03 | 6.95 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.45 | 21.24 | 15.65 | 7.44 | 7.71 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.61 | 12.58 | 9.95 | 13.99 | 10.49 | |||||
Inventory, 5 Yr. CAGR % | 3.15 | 7.55 | 15.16 | 5.59 | 7.62 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.38 | 8.76 | 5.87 | 0.17 | -0.94 | |||||
Total Assets, 5 Yr. CAGR % | 6.6 | 6.37 | 5.26 | 3.11 | 2.22 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.27 | 4.61 | 3.86 | 3.35 | 2.78 | |||||
Common Equity, 5 Yr. CAGR % | 4.4 | 4.71 | 3.89 | 3.13 | 2.62 | |||||
Cash From Operations, 5 Yr. CAGR % | 19.06 | 20.99 | 11.56 | 4.51 | 6.58 | |||||
Capital Expenditures, 5 Yr. CAGR % | -13.52 | -6.95 | -12.37 | -27.23 | -19.74 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 48.11 | 38.27 | 31.71 | 10.67 | 9.53 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 48.12 | 37.88 | 31.46 | 10.68 | 9.55 | |||||
Dividend Per Share, 5 Yr. CAGR % | 20.23 | 24.04 | 20.46 | 11.37 | 9.91 |
Select your edition
All financial news and data tailored to specific country editions